ACTA NEUROPHARMACOLOGICA››2011,Vol. 1››Issue (5): 1-7.
LI Dong-wei，DOU De-qiang
Online:2011-10-26Published:2013-03-24Contact:窦德强，男，教授，博士研究生导师；Tel：+86-0411-87406497，E-mail：doudeqiang7003@yahoo.com.cnAbout author:李东薇，女，硕士研究生；研究方向：中药药效物质基础；E-mail：wei-5599@163.comCLC Number:
LI Dong-wei, DOU De-qiang. Protective Effect of PPT and Ginsenoside-Re in MPP+-treated SH-SY5Y Cells[J]. ACTA NEUROPHARMACOLOGICA, 2011, 1(5): 1-7.
| [1]Steven Karceski. Parkinson disease and polyneuropathy[J]. Neurology, 2011, 77(22):e132-e134. [2]Halliday GM, Del Tredici K, Braak H. Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease [J]. J Neural Transm (Suppl), 2006, 70: 99-103. [3]Guo Hua, Song Junping. Latest research progress at home and abroad of pathogenesis of Parkinson’s disease[J]. Occupy and Health, 2012, 28(4):490-492. [4] Symptomatic pharmacological therapy in Parkinson’s disease [M]//Royal College of Physicians. Parkinson’s disease: national clinical guideline for diagnosis and management in primary and secondary care. London: the Lavenham Press Ltd, Sudbury, Suffolk, 2006: 59-97. [5] Mark R.Cookson. The biochemistry of Parkinson’s disease[J]. Annn Rev Biochem, 2005, 74:29-52. [6]张登本．神农本草经卷二[M]//全注全译神农本草经．第一版．北京：新世界出版社，2009：17-18. [7]吴崑著，宋白杨校注．中风门第一[M]//医方考脉语．第一版．北京：中国医药科技出版社，2012：10. [8]危亦林著，金芬芳校注．卷第十三风科[M]//世医得效方．第一版．北京：中国医药科技出版社，2011：256-257. [9]危亦林著，戴铭校注．卷第十三风科[M]//世医得效方．第二版．北京：中国医药科技出版社，2009：542. [10] 孙一奎著，周琦校注. 赤水玄珠[M]//赤水玄珠．第一版．北京：中国医药科技出版社，2011：495. [11] 解洪荣，张玉花，李雪松，等．MPTP/MPP+诱导的帕金森病实验模型的研究进展[J]．医学综述，2011，17（5）：669-672. [12] Celine A. Beamer, David M. Shepherd .Inhibition of TLR ligand- and interferon gamma-induced murine microglial activation by Panax notoginseng[J].J Neuroimmune Pharmacol, 2012, 7(2):465-476. [13] Zhang Xu, Yu Li, Bi Hong-tao, et al. Total fractionation and characterization of the water-soluble polysaccharides isolated from Panax ginseng C.A. Meyer[J]. Carbohydrate Polymer, 2009, 77(3):544-552. [14] Wang Jun, Xu Hua-min, Yang Hai-dong, et al. Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins[J]. Neurochem Int, 2009, 54(1):43-48. [15] Chen Li-min, Zhou Xiao-mian, Cao Ying-lin, et al. Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats[J]. J Asian Nat Prod Res, 2008, 10 (5-6):439-445. [16] Xu Bei-Bei, He Wen-fei, Lu Jin-cai, et al. Effects of ginsenoside Re on the levels of brain monoamines transmitters and serum corticosterone in water immersion-restraint rats[J].Natural product research development, 2009, 21(5):752-756, 786. [17] Liu Qian, Kou Jun-ping, Yu Bo-yang. Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation[J]. Neurochem Int, 2011,58(1):119-125. [18] Hu Sheng-quan, Han Ren-wen, Shinghung Mak, et al. Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells[J].J Ethnopharmacol, 2011, 135(1):34-42. |
| [1] | LI Hui, YANG Jin-shui, XUE Qian.A Case of Huntington's Disease with Involuntary Movements of the Limbs as the First Symptom Combined with Dysarthria in the Early Stages of the Disease[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(6): 31-. |
| [2] | ZHANG Yuan-qing, LIN Yu, HUANG Li.Study on the Effects of Vitamin D on DNA Methylation in Alzheimer's Disease Cell Models[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(6): 39-. |
| [3] | ZHAO Yu-ting, YIN Hong-yan, GUO Chun-yan.Explore the Mechanism of Paeoniae Radix Alba Delaying Alzheimer's Disease Based on Network Pharmacology and Molecular Docking[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 1-. |
| [4] | ZHANG Xin, YAO Si-fan, MA Meng-fan, SHEN Li-xia.Recent Progress in the Metabolomics of Alzheimer's Disease[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 47-. |
| [5] | YAO Si-fan, ZHANG Xin, SHEN Li-xia.Effects of Tau Protein on Mitochondrial Function in Alzheimer's Disease[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(4): 54-. |
| [6] | WANG Tian-xu, LIU Ci, CUI Yong-yuan, ZHANG Xin, WU Miao-miao, SHEN Li-xia.Explore the Mechanism of Quercetin in the Treatment of Alzheimer's Disease by Network Pharmacology and Molecular Docking[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(2): 31-. |
| [7] | YIN Hong-yan, YOU Si-han, GUO Chun-yan.Research Progress of Core Markers and Other Markers of Alzheimer's Disease[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(6): 45-. |
| [8] | ZHU Jing-yi , FAN Jian-chun, YU Ai-mei.Research Status on the Neuroprotective Effect of Probucol[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(6): 50-. |
| [9] | .Exploring the Effect and Mechanism of Pterostilbene on Alzheimer’s Disease Based on Network Pharmacology[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(5): 1-. |
| [10] | BAI Jing-ru, YOU Si-han, YIN Hong-yan, YANG Song-rui, GUO Chun-yan.Predicting the Target of Peach Kernel in the Treatment of Parkinson's Disease Based on Network Pharmacology[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(3): 31-. |
| [11] | LIU Hong-jie, PI Tian-long, WANG Gang, RONG Tie-cheng, MU Gui-yao, TIAN Jie-xiang.Musculoskeletal Ultrasound Evaluation of A Clinical Study of TGP in the Treatment of Rheumatoid Arthritis[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(2): 30-. |
| [12] | GUO Bao, LIU Zi-ming, JING Yong-shuai, ZHANG Dan-shen.Correlation Between Wnt Signaling Pathway and Alzheimer's Disease and Its Targets[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(1): 56-. |
| [13] | SI Wen-ying, HOU Yu-qing, SUN Xiao-jing, MENG Xian-yong, DONG Xiao-hua.Gene Therapy for Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(6): 51-56. |
| [14] | ZHANG Zhi-qing, ZHANG Yong-cai, LIU Lin-xuan, LI Ren-qing, LIU Ji-jia, DU Jing-kao, JIANG Bei, WEI Huiping, SU Li-ning.Bioinformatics Analysis of the Relationship between Exosomal ceRNA Regulatory Network and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 23-40. |
| [15] | CAI Yu-shan, ZHAO Shuai.Role of PPARβ/δ in Neurodegenerative Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 41-48. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
